Roche registers giredestrant Phase 3 trial; six other studies updateNov 6Weekly roundup, 16 itemsAbbViealectinibUpdated
Biogen posts Phase 4 RESPOND results for nusinersen after onasemnogene abeparvovecOct 30Trial updateBiogennusinersen
Novartis updates Phase IIIb ribociclib adjuvant breast cancer trial; four prior items holdOct 23Weekly roundup, 5 itemsarumakimigNovartisUpdated
Novartis clinicaltrials.gov records update across scleroderma, urticaria and SMA studiesOct 16Weekly roundup, 7 itemsianalumabNovartis
Novartis updates Leqvio label; MS study recruiting, thyroid study not yet recruitingAug 21Weekly roundup, 8 itemsGIA632inclisiran
Novartis: Myfortic label update approved; M.D. Anderson posts endometrial trial resultsJul 31Weekly roundup, 6 itemsabelacimabDDY391